Entamoeba histolytica
| Entamoeba histolytica | |
|---|---|
| Entamoeba histolytica trophozoite | |
| Scientific classification | |
| Domain: | Eukaryota |
| Clade: | Amorphea |
| Phylum: | Amoebozoa |
| Family: | Entamoebidae |
| Genus: | Entamoeba |
| Species: | E. histolytica
|
| Binomial name | |
| Entamoeba histolytica Schaudinn, 1903
| |
Entamoeba histolytica is an anaerobic parasitic amoebozoan, part of the genus Entamoeba.[1] Predominantly infecting humans and other primates causing amoebiasis, E. histolytica is estimated to infect about 35-50 million people worldwide.[1] E. histolytica infection is estimated to kill more than 55,000 people each year.[2] Previously, it was thought that 10% of the world population was infected, but these figures predate the recognition that at least 90% of these infections were due to a second species, E. dispar.[3] Mammals such as dogs and cats can become infected transiently, but are not thought to contribute significantly to transmission.
The word histolysis literally means disintegration and dissolution of organic tissues.
- ^ a b Rawat A, Singh P, Jyoti A, Kaushik S, Srivastava VK (August 2020). "Averting transmission: A pivotal target to manage amoebiasis". Chemical Biology & Drug Design. 96 (2): 731–744. doi:10.1111/cbdd.13699. PMID 32356312. S2CID 218475533.
- ^ Shirley DT, Farr L, Watanabe K, Moonah S (July 2018). "A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis". Open Forum Infectious Diseases. 5 (7): ofy161. doi:10.1093/ofid/ofy161. PMC 6055529. PMID 30046644.
- ^ "Amoebiasis" (PDF). Relevé Épidémiologique Hebdomadaire. 72 (14): 97–99. April 1997. PMID 9100475.